Pooled Safety Analysis from Phase I-III Studies for Patients with Hematological Malignancies Treated with the PI3K Inhibitor Copanlisib
64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, pp.6470-6473, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Doi Number: 10.1182/blood-2022-167368
- City: Louisiana
- Country: United States Of America
- Page Numbers: pp.6470-6473
- Ankara University Affiliated: Yes